ETFsBloomberg MSCI ESG Global Corporate A+ 1-5 Year Select Index USD Hedged
Amundi

Amundi Global Corporate Bond 1-5Y Highest Rated ESG UCITS ETF USD Hedged Acc

GCRE XETRAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
99.65EUR
-0.02% · -€0.02
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
GCREBase
Fund charges
0.18%Total expense ratio (TER)
Fund size
€661Mall share classes
Return 1Y
+4.4%
Sharpe 3Y
Not published
Volatility 1Y
5.1%annualised
Holdings
1,962Fund holdings

Performance

Compare
  • GCRE+4.4%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
GCRE+1.0%+3.0%+5.3%+6.2%+4.4%--
MSCI World-2.8%-0.6%+7.8%+14.0%+14.1%+65.6%+64.8%
Gap to MSCI World+3.8%+3.7%-2.6%-7.8%-9.7%--

Risk and return

Sharpe ratio · 1Y
0.62
Below MSCI World · 1.28
Return p.a.
+5.3%
Volatility
5.1%
Max loss
-3.4%Jan 2026

Sharpe vs indices

MSCI World
1.28
S&P 500
1.16
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
GCRE
0.62
CAC 40
-0.01
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
2.5%
Holdings
1,962
As of
Fund holdings
  1. 1BANK OF AMER VAR Dec28US06051GHD430.30%
  2. 2ABBVIE INC 3.2% Nov29US00287YBX670.27%
  3. 3WELLS FARGO C VAR Oct30US95000U2G700.25%
  4. 4SALESFORCE IN 4.5% Mar28US79466LAQ770.25%
  5. 5DEUTSCHE TELE 8.75% Jun30US25156PAC770.24%
  6. 6NVIDIA CORP 4.5% Jun31US67066GAR560.24%
  7. 7WELLS FARGO C VAR Jan31US95000U3P600.24%
  8. 8WELLS FARGO C VAR Feb31US95000U2J100.23%
  9. 9MORGAN STANLE VAR Jan29US61744YAP340.22%
  10. 10PFIZER INVSTM 4.45% May28US716973AC670.22%

Countries

Classified 100.0%
Largest
53.8%United States
Top 3
68.8%
Effective number
3.21 / HHI

Market cap

Weight vs holdings

2.5%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.